Takeda Appoints Jostein Davidsen Head of Emerging Markets

Takeda Appoints Jostein Davidsen Head of Emerging Markets

ID: 76542

(Thomson Reuters ONE) -
Nycomed /
Takeda Appoints Jostein Davidsen Head of Emerging Markets
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.

Nycomed, a Takeda Company, today announced that Jostein Davidsen has been
appointed Head of Emerging Markets in addition to his current role as Area Head
of Russia/CIS. He will report to Frank Morich, EVP, International Operations
(Americas/Europe), Takeda Pharmaceuticals International, and CEO of Nycomed. The
appointment is effective immediately.

Nycomed's presence in Emerging Markets was a key driver for Takeda to acquire
Nycomed at the end of September 2011. These fast-growing markets are an
important lever to achieve Takeda's sustainable growth aspirations as outlined
in the 2011-2013 Mid-Range-Plan. The Emerging Markets Region comprises
Russia/CIS, Latin America, Middle East-Turkey-Africa, and South Asia.

"Jostein's strong track record of leading Russia/CIS over the past 17 years
makes him an ideal candidate for this position." said Frank Morich, EVP,
International Operations (Americas/Europe), Takeda Pharmaceuticals International
and CEO, Nycomed. "His extensive knowledge of the industry, combined with vision
and tenacity, has propelled Russia/CIS to become one of Nycomed's top revenue
contributors."

Jostein Davidsen has been leading the legacy Nycomed Russia/CIS area since
1994. Since then, the region has grown into the company's largest market. Today,
Nycomed: a Takeda Company is among the top 10 companies in sales in Russia and
all of the CIS pharmaceutical markets and has outpaced average market growth
more than two times in the last decade. In 2010, Russia/CIS had total sales of
?479 million, growing by 31% in local currencies. The company has established
itself as a preferred partner for international pharmaceutical companies in




Russia/CIS. Nycomed is investing in a pharmaceutical manufacturing facility in
Yaroslavl, making it one of the first international companies in Russia to take
such a step.

About Nycomed: a Takeda Company
Nycomed is a Takeda company since end of September 2011. Takeda is a research-
based global company with its main focus on pharmaceuticals. The combined
company has an active commercial presence in the therapeutic areas of metabolic
diseases, gastroenterology, oncology, cardiovascular health, CNS diseases,
inflammatory and immune disorders, respiratory diseases and pain management.

Takeda's traditional strengths in North America, Japan, and the rest of Asia,
are now complemented by Nycomed's position in Europe and the high growth
emerging markets. The combined company has a presence in more than 70 countries
worldwide, and ranked 12th by global Rx sales, 14th in the BRIC countries and
18th in Europe.

About Takeda
As the largest pharmaceutical company in Japan and one of the global leaders of
the industry, Takeda is committed to strive towards better health for patients
worldwide through leading innovation in medicine. Additional information about
Takeda is available through its corporate website,www.takeda.com.


Contact
Nycomed Corporate Communications
Phone: +41 44 555 1510

Tobias Cottmann
Phone: +41 44 555 1501
tobias.cottmann(at)nycomed.com


--- End of Message ---

Nycomed
Thurgauerstrasse 130 Glattpark-Opfikon Switzerland



Press Release Jostein Davidsen DE:
http://hugin.info/144179/R/1555213/479615.pdf

Press Release Jostein Davidsen EN:
http://hugin.info/144179/R/1555213/479614.pdf




This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Nycomed via Thomson Reuters ONE

[HUG#1555213]


Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  DNO PROVIDES MARKET UPDATE Chaarat Gold Holdings Ltd : Directorate changes
Bereitgestellt von Benutzer: hugin
Datum: 17.10.2011 - 09:59 Uhr
Sprache: Deutsch
News-ID 76542
Anzahl Zeichen: 4482

contact information:
Town:

Glattpark-Opfikon



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 232 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Takeda Appoints Jostein Davidsen Head of Emerging Markets"
steht unter der journalistisch-redaktionellen Verantwortung von

Nycomed (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Nycomed



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z